Department of Drug Administration Drug Recall Notice
Department of Drug Administration – DDA Drug Recall Notice | Published: 05/18/2077
During the market monitoring, the samples collected from Department of Drug Administration – DDA were tested and found to be of low quality. This information has been published for the information of the concerned industry to stop the sale and distribution of these drugs as per Section 14 of the Drugs Act 2035 and to recall them immediately from the market and submit the details to the Department of Drug Administration – DDA. Also, all concerned are requested not to recommend, sell, distribute or even use these drugs.
For more visit: www.dda.gov.np
If you have any complaints, information, or suggestions about the content published on Pharma Info Nepal, please feel free to contact at info@pharmainfonepal.com. Thanks for visiting us.
Related Post:
- DDA Drug Recall Notice
- INCB, WHO and UNODC statement on access to internationally controlled medicines during COVID-19 pandemic
- Department of Drug Administration – DDA Urgent Notice Regarding Drug Recall
- Department of Drug Administration & DDA Urgent Notice Regarding Drug Recall
- Urgent Information Regarding Drug RECALL & Department of Drug Administration
- Department of Drug Administration Notice Regarding Misinformation of Covid-19
Follow Our Facebook Page : Pharma Info Nepal
Pharma Info Nepal (Nabin’s Blog) is Popular Pharmacy information sharing online platform initiated by Nabin Bist since 2019. Thousands of Pharmacy professionals have trusted Pharma Info Nepal as a right blog to find the latest Pharma opportunities, information & resources for pharmacy updates in Nepal . If you have any complaints, information, or suggestions about the content published on Pharma Info Nepal/If you also like to write an article, please feel free to contact at info@pharmainfonepal.com. Thanks for visiting us.
Nepal’s Leading Pharma Portal | Complete Pharma Updates
